TEBU-BIO ApS: Financial statements 2020
CVR: 10156920
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TEBU-BIO ApS (CVR 10156920) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,169,802 and a net result of DKK 471,838 compared with DKK 85,847 the year before. That is an increase of 76.9% compared with the year before. Equity in the 2020 report amounted to DKK 682,749. The solvency ratio was 42.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,169,802
- Profit/Loss
- DKK 471,838
- Equity
- DKK 682,749
- Total Assets
- DKK 1,592,962
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.2 mio. | 472 t. | 683 t. | 1 |
| 2019 | - | 661 t. | 86 t. | 211 t. | 1 |
| 2018 | - | 655 t. | 128 t. | 280 t. | 1 |
| 2017 | - | 525 t. | 9 t. | 152 t. | 1 |
| 2016 | - | 862 t. | 247 t. | 383 t. | 1 |
Official annual report
How creditworthy is TEBU-BIO ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
TEBU-BIO ApS has published its annual report for 2019. Gross profit came to DKK 661,381, and the net result was DKK 85,847.
About TEBU-BIO ApS
TEBU-BIO ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Donald van Dijk. The company is owned by Tebu bio S.A.. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,064,139 and a net result of DKK -414,038 compared with DKK -60,754 the year before. Equity in the 2025 report amounted to DKK -12,652.